0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-3T12431
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medication Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-3T12431
Report
September 2024
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medication - Market Size

The global market for Medication was estimated to be worth US$ 1475000 million in 2023 and is forecast to a readjusted size of US$ 2075470 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Medication - Market

Medication - Market

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medication by region & country, by Type, and by Application.
The Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medication.
Market Segmentation

Scope of Medication - Market Report

Report Metric Details
Report Name Medication - Market
Forecasted market size in 2030 US$ 2075470 million
CAGR 5.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Takeda, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Medication manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Medication - Market size in 2030?

Ans: The Medication - Market size in 2030 will be US$ 2075470 million.

Who are the main players in the Medication - Market report?

Ans: The main players in the Medication - Market are Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Takeda, Boehringer Ingelheim

What are the Application segmentation covered in the Medication - Market report?

Ans: The Applications covered in the Medication - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Medication - Market report?

Ans: The Types covered in the Medication - Market report are Brand Drugs, Generic Drug

Recommended Reports

Drug Therapeutics

Drug Technology

Specialty Drugs

1 Market Overview
1.1 Medication Product Introduction
1.2 Global Medication Market Size Forecast
1.3 Medication Market Trends & Drivers
1.3.1 Medication Industry Trends
1.3.2 Medication Market Drivers & Opportunity
1.3.3 Medication Market Challenges
1.3.4 Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medication Players Revenue Ranking (2023)
2.2 Global Medication Revenue by Company (2019-2024)
2.3 Key Companies Medication Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medication Product Offered
2.5 Key Companies Time to Begin Mass Production of Medication
2.6 Medication Market Competitive Analysis
2.6.1 Medication Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medication Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Brand Drugs
3.1.2 Generic Drug
3.2 Global Medication Sales Value by Type
3.2.1 Global Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medication Sales Value, by Type (2019-2030)
3.2.3 Global Medication Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Medication Sales Value by Application
4.2.1 Global Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medication Sales Value, by Application (2019-2030)
4.2.3 Global Medication Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medication Sales Value by Region
5.1.1 Global Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medication Sales Value by Region (2019-2024)
5.1.3 Global Medication Sales Value by Region (2025-2030)
5.1.4 Global Medication Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medication Sales Value, 2019-2030
5.2.2 North America Medication Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medication Sales Value, 2019-2030
5.3.2 Europe Medication Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medication Sales Value, 2019-2030
5.4.2 Asia Pacific Medication Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medication Sales Value, 2019-2030
5.5.2 South America Medication Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medication Sales Value, 2019-2030
5.6.2 Middle East & Africa Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medication Sales Value
6.3 United States
6.3.1 United States Medication Sales Value, 2019-2030
6.3.2 United States Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medication Sales Value, 2019-2030
6.4.2 Europe Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medication Sales Value, 2019-2030
6.5.2 China Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medication Sales Value, 2019-2030
6.6.2 Japan Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medication Sales Value, 2019-2030
6.7.2 South Korea Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medication Sales Value, 2019-2030
6.9.2 India Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Medication Products, Services and Solutions
7.1.4 Pfizer Medication Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Medication Products, Services and Solutions
7.2.4 Roche Medication Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Sanofi
7.3.1 Sanofi Profile
7.3.2 Sanofi Main Business
7.3.3 Sanofi Medication Products, Services and Solutions
7.3.4 Sanofi Medication Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Medication Products, Services and Solutions
7.4.4 Johnson & Johnson Medication Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Recent Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Profile
7.5.2 Merck & Co. (MSD) Main Business
7.5.3 Merck & Co. (MSD) Medication Products, Services and Solutions
7.5.4 Merck & Co. (MSD) Medication Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co. (MSD) Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Medication Products, Services and Solutions
7.6.4 Novartis Medication Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 AbbVie
7.7.1 AbbVie Profile
7.7.2 AbbVie Main Business
7.7.3 AbbVie Medication Products, Services and Solutions
7.7.4 AbbVie Medication Revenue (US$ Million) & (2019-2024)
7.7.5 AbbVie Recent Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Profile
7.8.2 Gilead Sciences Main Business
7.8.3 Gilead Sciences Medication Products, Services and Solutions
7.8.4 Gilead Sciences Medication Revenue (US$ Million) & (2019-2024)
7.8.5 Gilead Sciences Recent Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Profile
7.9.2 GlaxoSmithKline (GSK) Main Business
7.9.3 GlaxoSmithKline (GSK) Medication Products, Services and Solutions
7.9.4 GlaxoSmithKline (GSK) Medication Revenue (US$ Million) & (2019-2024)
7.9.5 GlaxoSmithKline (GSK) Recent Developments
7.10 Amgen
7.10.1 Amgen Profile
7.10.2 Amgen Main Business
7.10.3 Amgen Medication Products, Services and Solutions
7.10.4 Amgen Medication Revenue (US$ Million) & (2019-2024)
7.10.5 Amgen Recent Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Profile
7.11.2 AstraZeneca Main Business
7.11.3 AstraZeneca Medication Products, Services and Solutions
7.11.4 AstraZeneca Medication Revenue (US$ Million) & (2019-2024)
7.11.5 AstraZeneca Recent Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Profile
7.12.2 Bristol-Myers Squibb Main Business
7.12.3 Bristol-Myers Squibb Medication Products, Services and Solutions
7.12.4 Bristol-Myers Squibb Medication Revenue (US$ Million) & (2019-2024)
7.12.5 Bristol-Myers Squibb Recent Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Profile
7.13.2 Eli Lilly Main Business
7.13.3 Eli Lilly Medication Products, Services and Solutions
7.13.4 Eli Lilly Medication Revenue (US$ Million) & (2019-2024)
7.13.5 Eli Lilly Recent Developments
7.14 Teva
7.14.1 Teva Profile
7.14.2 Teva Main Business
7.14.3 Teva Medication Products, Services and Solutions
7.14.4 Teva Medication Revenue (US$ Million) & (2019-2024)
7.14.5 Teva Recent Developments
7.15 Bayer
7.15.1 Bayer Profile
7.15.2 Bayer Main Business
7.15.3 Bayer Medication Products, Services and Solutions
7.15.4 Bayer Medication Revenue (US$ Million) & (2019-2024)
7.15.5 Bayer Recent Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Profile
7.16.2 Novo Nordisk Main Business
7.16.3 Novo Nordisk Medication Products, Services and Solutions
7.16.4 Novo Nordisk Medication Revenue (US$ Million) & (2019-2024)
7.16.5 Novo Nordisk Recent Developments
7.17 AbbVie
7.17.1 AbbVie Profile
7.17.2 AbbVie Main Business
7.17.3 AbbVie Medication Products, Services and Solutions
7.17.4 AbbVie Medication Revenue (US$ Million) & (2019-2024)
7.17.5 AbbVie Recent Developments
7.18 Takeda
7.18.1 Takeda Profile
7.18.2 Takeda Main Business
7.18.3 Takeda Medication Products, Services and Solutions
7.18.4 Takeda Medication Revenue (US$ Million) & (2019-2024)
7.18.5 Takeda Recent Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Profile
7.19.2 Boehringer Ingelheim Main Business
7.19.3 Boehringer Ingelheim Medication Products, Services and Solutions
7.19.4 Boehringer Ingelheim Medication Revenue (US$ Million) & (2019-2024)
7.19.5 Boehringer Ingelheim Recent Developments
8 Industry Chain Analysis
8.1 Medication Industrial Chain
8.2 Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medication Sales Model
8.5.2 Sales Channel
8.5.3 Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Medication Market Trends
    Table 2. Medication Market Drivers & Opportunity
    Table 3. Medication Market Challenges
    Table 4. Medication Market Restraints
    Table 5. Global Medication Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Medication Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Medication Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Medication Product Type
    Table 9. Key Companies Time to Begin Mass Production of Medication
    Table 10. Global Medication Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Medication Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Medication Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Medication Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Medication Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Medication Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Medication Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Medication Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Medication Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Medication Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Medication Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Medication Sales Value by Region (2019-2024) & (%)
    Table 27. Global Medication Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Medication Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Medication Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Medication Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Medication Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Roche Basic Information List
    Table 37. Roche Description and Business Overview
    Table 38. Roche Medication Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Medication Business of Roche (2019-2024)
    Table 40. Roche Recent Developments
    Table 41. Sanofi Basic Information List
    Table 42. Sanofi Description and Business Overview
    Table 43. Sanofi Medication Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Medication Business of Sanofi (2019-2024)
    Table 45. Sanofi Recent Developments
    Table 46. Johnson & Johnson Basic Information List
    Table 47. Johnson & Johnson Description and Business Overview
    Table 48. Johnson & Johnson Medication Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Medication Business of Johnson & Johnson (2019-2024)
    Table 50. Johnson & Johnson Recent Developments
    Table 51. Merck & Co. (MSD) Basic Information List
    Table 52. Merck & Co. (MSD) Description and Business Overview
    Table 53. Merck & Co. (MSD) Medication Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Medication Business of Merck & Co. (MSD) (2019-2024)
    Table 55. Merck & Co. (MSD) Recent Developments
    Table 56. Novartis Basic Information List
    Table 57. Novartis Description and Business Overview
    Table 58. Novartis Medication Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Medication Business of Novartis (2019-2024)
    Table 60. Novartis Recent Developments
    Table 61. AbbVie Basic Information List
    Table 62. AbbVie Description and Business Overview
    Table 63. AbbVie Medication Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Medication Business of AbbVie (2019-2024)
    Table 65. AbbVie Recent Developments
    Table 66. Gilead Sciences Basic Information List
    Table 67. Gilead Sciences Description and Business Overview
    Table 68. Gilead Sciences Medication Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Medication Business of Gilead Sciences (2019-2024)
    Table 70. Gilead Sciences Recent Developments
    Table 71. GlaxoSmithKline (GSK) Basic Information List
    Table 72. GlaxoSmithKline (GSK) Description and Business Overview
    Table 73. GlaxoSmithKline (GSK) Medication Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Medication Business of GlaxoSmithKline (GSK) (2019-2024)
    Table 75. GlaxoSmithKline (GSK) Recent Developments
    Table 76. Amgen Basic Information List
    Table 77. Amgen Description and Business Overview
    Table 78. Amgen Medication Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Medication Business of Amgen (2019-2024)
    Table 80. Amgen Recent Developments
    Table 81. AstraZeneca Basic Information List
    Table 82. AstraZeneca Description and Business Overview
    Table 83. AstraZeneca Medication Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Medication Business of AstraZeneca (2019-2024)
    Table 85. AstraZeneca Recent Developments
    Table 86. Bristol-Myers Squibb Basic Information List
    Table 87. Bristol-Myers Squibb Description and Business Overview
    Table 88. Bristol-Myers Squibb Medication Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Medication Business of Bristol-Myers Squibb (2019-2024)
    Table 90. Bristol-Myers Squibb Recent Developments
    Table 91. Eli Lilly Basic Information List
    Table 92. Eli Lilly Description and Business Overview
    Table 93. Eli Lilly Medication Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Medication Business of Eli Lilly (2019-2024)
    Table 95. Eli Lilly Recent Developments
    Table 96. Teva Basic Information List
    Table 97. Teva Description and Business Overview
    Table 98. Teva Medication Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Medication Business of Teva (2019-2024)
    Table 100. Teva Recent Developments
    Table 101. Bayer Basic Information List
    Table 102. Bayer Description and Business Overview
    Table 103. Bayer Medication Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Medication Business of Bayer (2019-2024)
    Table 105. Bayer Recent Developments
    Table 106. Novo Nordisk Basic Information List
    Table 107. Novo Nordisk Description and Business Overview
    Table 108. Novo Nordisk Medication Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Medication Business of Novo Nordisk (2019-2024)
    Table 110. Novo Nordisk Recent Developments
    Table 111. AbbVie Basic Information List
    Table 112. AbbVie Description and Business Overview
    Table 113. AbbVie Medication Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Medication Business of AbbVie (2019-2024)
    Table 115. AbbVie Recent Developments
    Table 116. Takeda Basic Information List
    Table 117. Takeda Description and Business Overview
    Table 118. Takeda Medication Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Medication Business of Takeda (2019-2024)
    Table 120. Takeda Recent Developments
    Table 121. Boehringer Ingelheim Basic Information List
    Table 122. Boehringer Ingelheim Description and Business Overview
    Table 123. Boehringer Ingelheim Medication Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Medication Business of Boehringer Ingelheim (2019-2024)
    Table 125. Boehringer Ingelheim Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Medication Downstream Customers
    Table 129. Medication Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Medication Product Picture
    Figure 2. Global Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Medication Sales Value (2019-2030) & (US$ Million)
    Figure 4. Medication Report Years Considered
    Figure 5. Global Medication Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Medication Revenue in 2023
    Figure 7. Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Brand Drugs Picture
    Figure 9. Generic Drug Picture
    Figure 10. Global Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Medication Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Other
    Figure 15. Global Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Medication Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Medication Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Medication Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Medication Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Medication Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Medication Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Medication Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Medication Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Medication Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Medication Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Medication Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Medication Sales Value (%), (2019-2030)
    Figure 28. United States Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Medication Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Medication Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Medication Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Medication Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Medication Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Medication Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Medication Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Medication Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Medication Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Medication Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Medication Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Medication Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Medication Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Medication Sales Value by Application (%), 2023 VS 2030
    Figure 49. Medication Industrial Chain
    Figure 50. Medication Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS